Notable insider buying and selling activity across public companies.
Tracking and analysis of reported insider transactions, including executive and director buying or selling. Insider activity can offer insight into internal confidence, valuation perceptions, and potential inflection points.
11,898 total articles
Insulet Corp director Michael R. Minogue bought 2,030 shares on February 25, 2026, paying a weighted average of $246.23 for a total of $499,846. The purchase occurs while the stock trades near $248.12 and InvestingPro flags the shares as undervalued relative to Fair Value. The medical device maker reported $784 million in fourth-quarter 2025 revenu…
Jude Schramm, Executive Vice President and Chief Information Officer of Fifth Third Bancorp (NASDAQ: FITB), executed a series of transactions on February 23 and 24, 2026 that included the sale of 11,396 shares for $757,514, the exercise of stock appreciation rights for 14,228 shares valued at $380,172, and the disposition of 10,332 shares to cover …
Avnet CEO Philip R. Gallagher sold 46,068 shares of company stock on February 24, 2026, for roughly $3.1 million while exercising options to acquire 46,068 shares the same day. The trades occurred as Avnet's shares have climbed about 40% year-to-date and following quarterly results that beat earnings and revenue forecasts.
Hans Erik Vestberg, a director of Verizon Communications Inc. (VZ), sold 225,000 shares of the company's common stock on February 24, 2026, for proceeds totaling $11,163,150. The transaction - executed across prices from $49.395 to $49.865 per share - took place with Verizon trading close to a 52-week high of $50.48 following an almost 23% year-to-…
DT Midstream Executive Vice President and CFO Jeffrey A. Jewell purchased 185 shares of the company's common stock on February 25, 2026, for $136.33 apiece, a transaction valued at $25,221. After the purchase Jewell holds 89,582.78 shares. The company’s fourth-quarter 2025 results were mixed - EPS of $1.08 missed the $1.17 forecast while revenue of…
Williams Companies SVP and General Counsel Terrance Lane Wilson sold 27,000 shares on February 24, 2026 for about $1.97 million after exercising options the previous day. The filings show option exercises, issuer share withholdings for tax obligations, and an updated post-transaction ownership stake. The company has also seen fresh analyst price-ta…
IBM director Michelle J. Howard purchased 50 shares of International Business Machines Corp. on February 25, 2026, paying $237.83 per share for a total of $11,891. The trade leaves her with 194 shares directly held. The purchase takes place while IBM shares have fallen 19% year-to-date and recently edged down 7.3% over the prior week, trading close…
Michael Dean Brown, Director and President & CEO of Travel & Leisure Co. (NYSE: TNL), sold common stock on February 23-24, 2026, totaling $6.89 million and exercised options to acquire additional shares at an exercise price of $44.38 for a cumulative value of $4,118,375. After these moves, Brown directly holds 427,821 shares. Separately, Travel + L…
Gabrielle B. Toledano, a director at IonQ, Inc. (NASDAQ: IONQ), sold 616 shares on February 24, 2026, for $19,096 at $31 per share under a Rule 10b5-1 plan. The stock has since traded up to $33.59 but remains about 25% lower year-to-date. IonQ reported stronger-than-expected fourth-quarter 2025 results, with EPS of -$0.20 compared with an expected …
Carter Deon, Vice President and President CAPV of Olin Corp, sold 6,500 shares of company stock on February 25, 2026, for roughly $154,225. The transaction, disclosed on a Form 4 filing with the SEC, comes amid a wave of analyst rating actions and price-target cuts driven by a weaker earnings outlook for 2026 across key Olin business lines.
Moderna President Stephen Hoge sold 160,009 shares on February 23, 2026, at $48.84 per share under a Rule 10b5-1 plan, realizing roughly $7.8 million, and exercised options to acquire the same number of shares at $19.15. The moves come while Moderna shares hover near a 52-week high following a substantial six-month rally, and after the company repo…
Vikram Gupta, Senior Vice President at Synaptics Incorporated (NASDAQ: SYNA), sold 772 shares on February 25, 2026, for approximately $62,972 at $81.57 per share under a 10b5-1 plan. After the transaction Gupta holds 95,996 shares. Separately, Synaptics posted Q2 fiscal 2026 results that topped analyst estimates on both EPS and revenue, yet the sto…
Coliseum Capital Management and related entities purchased a total of $9.14 million in Sonos Inc. (SONO) common stock in multiple transactions executed between February 23 and February 25, 2026. The acquisitions - executed at prices between $14.53 and $15.40 per share - increased the combined holdings of the firms and named individuals to 16,921,84…
Blackbaud Inc.'s Executive Vice President and Chief Technology Officer, Kevin McDearis, sold 15,462 shares on February 23, 2026, in two transactions totaling roughly $717,850, according to a Form 4 filing. The filing also records shares issued from vesting of performance-restricted units and shares sold to cover tax obligations. These moves come as…
Blackbaud executive vice president and chief commercial officer David J. Benjamin sold 14,349 shares on February 24, 2026, generating approximately $681,108. The Form 4 filing shows additional February 23 disposals to meet tax obligations, the vesting of performance restricted stock units, and an unchanged post-transaction holding of 73,124 shares.…
Hercules Capital director Robert P. Badavas acquired 5,000 shares on February 24, 2026, spending $75,050. The purchase comes while HTGC trades near its 52-week low and the company reports a modest increase in quarter-end net asset value per share. Piper Sandler lowered its rating and price target, and Hercules amended a loan agreement with Savara t…
Neal West, Executive Vice President and Chief Financial Officer of Kaiser Aluminum, sold 5,000 shares on February 23, 2026, in multiple trades that generated roughly $608,600. The stock has risen sharply over the last 12 months and is currently trading above InvestingPro’s Fair Value estimate. Kaiser reported better-than-expected fourth-quarter 202…
Arvinas Chief Accounting Officer David K. Loomis sold 1,108 shares on February 23, 2026, in an automatic transaction to cover tax obligations. The company has reported weak fourth-quarter 2025 financials while continuing clinical progress, and an analyst has adjusted the price target while keeping a Neutral stance.
Arvinas Chief Scientific Officer Angela M. Cacace had 3,609 shares sold automatically on February 23, 2026 to satisfy tax withholding connected to vested RSUs. The disposals were carried out at $12.16 per share, generating $43,885 in proceeds. The stock has since climbed to $13.30, posting a 76% six-month gain, while the company reported weaker-tha…
Alexander L. Cappello, a director at Cheesecake Factory Inc., sold 635 shares on February 23, 2026, totaling $40,474. The sale comes as CAKE stock has climbed more than 30% year-to-date. The company reported fiscal Q4 2025 results that modestly exceeded expectations but disclosed a drop in comparable restaurant sales. Analysts remain divided, citin…
Randy Teel, president and chief executive of Arvinas, Inc. (NASDAQ: ARVN), sold 4,786 shares of company stock on February 23, 2026, in two automatic transactions to satisfy tax withholding obligations tied to vested restricted stock units. The shares were sold at $12.16 each for roughly $58,197, a price below the company’s quoted $13.30 market pric…
Mitsui Sumitomo Insurance Co., Ltd. acquired $39,381,431 of common stock in W. R. Berkley Corporation (NYSE: WRB) across multiple transactions executed between February 23 and February 25, 2026. The purchases were made under a Rule 10b5-1 plan adopted October 3, 2025. W. R. Berkley reported fourth-quarter 2025 revenue above analyst expectations, EP…
EverCommerce Inc. CEO Eric Richard Remer sold 11,490 shares of common stock on February 25, 2026, for about $120,903 under a Rule 10b5-1 trading plan. Following the sale, Remer retains substantial direct and indirect stakes in the company. Separately, Raymond James and RBC Capital issued downgrades affecting Weave Communications and EverCommerce, r…
Kymera Therapeutics Chief Executive Officer executed a near $2.7 million stock sale and exercised options to acquire additional shares, while the company advances Phase 2b testing of KT-621 and secures an FDA Fast Track designation for atopic dermatitis. Analysts remain divided on catalysts and valuation.
Director Jennifer S. Grafton sold 1,600 shares of Farmland Partners Inc. (NYSE: FPI) on February 24, 2026, for $12.36 per share, totaling $19,776. The transaction, carried out under a Rule 10b5-1 plan adopted in November 2025, leaves Grafton with 10,400 shares. The sale coincides with FPI trading close to its 52-week high of $13 and a 34.6% year-to…
